Inhibikase Therapeutics

Inhibikase is a company dedicated to the development and commercialization of small molecule kinase inhibitor therapeutics for the safe and effective treatment of neurodegeneration inside and outside the brain. Kinase inhibitors that block abnormal activation of protein kinases are a recognized class of drugs for cancer treatment. Inhibikase is leveraging established knowledge of clinically validated kinase inhibitor drugs targeting non-CNS disorders to create novel targeted therapies for neurodegenerative diseases and other conditions.